Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Not applicable Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20121
20141
20151
20162
20182
20193
20201
20212
20222
20231
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status7
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Hospital for Sick Children3
Centre for Addiction and Mental Health2
IWK Health Centre2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
University of Toronto2
Université du Québec a Montréal2
Cambridge Memorial Hospital1
Lily Hechtman1
McGill University1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity23
Attention Deficit and Disruptive Behavior Disorders2
Autism Spectrum Disorder2
Conduct Disorder2
Learning Disabilities2
Mental Disorders2
Oppositional Defiant Disorder2
Antisocial Personality Disorder1
Anxiety Disorders1
Brain Injuries, Traumatic1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.